Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung

Blood

Volumn 113, Issue 22, 2009, Pages 5588-5598

  Wygrecka, Malgorzata ^a   Marsh, Leigh M ^a   Morty, Rory E ^a   Henneke, Ingrid ^a   Guenther, Andreas ^a   Lohmeyer, Juergen ^a   Markart, Philipp ^a   Preissner, Klaus T ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; ENOLASE 1; LIPOPOLYSACCHARIDE; PLASMIN; PLASMINOGEN; UNCLASSIFIED DRUG; ANTIBODY; DNA BINDING PROTEIN; ENO1 PROTEIN, HUMAN; MEMBRANE ANTIGEN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL STRAIN U937; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; MONOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; CELL ADHESION; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

ACUTE DISEASE; ANIMALS; ANTIBODIES; ANTIGENS, SURFACE; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DNA-BINDING PROTEINS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MONOCYTES; PHOSPHOPYRUVATE HYDRATASE; PLASMINOGEN; PNEUMONIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; U937 CELLS;

EID: 67049088421     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-170837     Document Type: Article

References (50)

1. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol. 2006;18:49-53.
2. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968;128: 415-435.
3. Randolph GJ, Jakubzick C, Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol. 2008;20:52-60.
4. van Lookeren Campagne M, Wiesmann C, Brown EJ. Macrophage complement receptors and pathogen clearance. Cell Microbiol. 2007;9:2095-2102. (Pubitemid 47250283)
5. Maus UA, Wellmann S, Hampl C, et al. CCR2- positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. Am J Physiol Lung Cell Mol Physiol. 2005;288:L350-L358. (Pubitemid 40105374)
6. Maus UA, Waelsch K, Kuziel WA, et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol. 2003;170:3273-3278.
7. Goto Y, Hogg JC, Whalen B, Shih CH, Ishii H, Van Eeden SF. Monocyte recruitment into the lungs in pneumococcal pneumonia. Am J Respir Cell Mol Biol. 2004;30:620-626.
8. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med. 2002;8:1235-1242. (Pubitemid 35373554)
9. Nocito A, Dahm F, Jochum W, et al. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res. 2008;68:5152-5158.
10. Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem. 1985;260:4303-4311. (Pubitemid 15091978)
11. Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem. 1986;261:11656-11662. (Pubitemid 17206086)
12. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986;103:2411-2420. (Pubitemid 17216665)
13. Chapman HA Jr, Vavrin Z, Hibbs JB Jr. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell. 1982; 28:653-662.
14. Haraguchi M, Border WA, Huang Y, Noble NA. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int. 2001;59:2146-2155. (Pubitemid 32467606)
15. Loskutoff DJ, Quigley JP. PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest. 2000;106:1441-1443.
16. Herren T, Swaisgood C, Plow EF. Regulation of plasminogen receptors. Front Biosci. 2003;8: d1-8.
17. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost. 1987;58:936-942.
18. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell surface lysines in plasminogen binding to cells: identification of alphaenolase as a candidate plasminogen receptor. Biochemistry. 1991;30:1682-1691.
19. Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem. 1995;227:407-415.
20. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem. 1994;269:21191-21197.
21. Falcone DJ, Borth W, Khan KM, Hajjar KA. Plasminogen- mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood. 2001;97:777-784. (Pubitemid 32113413)
22. MacLeod TJ, Kwon M, Filipenko NR, Waisman DM. Phospholipid-associated annexin A2- S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem. 2003;278:25577-25584. (Pubitemid 36835310)
23. Herren T, Burke TA, Das R, Plow EF. Identification of histone H2B as a regulated plasminogen receptor. Biochemistry. 2006;45:9463-9474. (Pubitemid 44223250)
24. Miles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry. 1989;28:9337-9343.
25. Hawley SB, Green MA, Miles LA. Discriminating between cell surface and intracellular plasminogen- binding proteins: heterogeneity in profibrinolytic plasminogen-binding proteins on monocytoid cells. Thromb Haemost. 2000;84:882-890.
26. Derbise A, Song YP, Parikh S, Fischetti VA, Pancholi V. Role of the C-terminal lysine residues of streptococcal surface enolase in Glu- and Lys-plasminogen- binding activities of group A streptococci. Infect Immun. 2004;72:94-105. (Pubitemid 38018166)
27. Bergmann S, Rohde M, Chhatwal GS, Hammerschmidt S. Alpha-enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol. 2001;40:1273-1287. (Pubitemid 32635298)
28. Bergmann S, Rohde M, Preissner KT, Hammerschmidt S. The nine residue plasminogen- binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin, and transmigration. Thromb Haemost. 2005;94: 304-311. (Pubitemid 41122484)
29. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med. 1983;158:393-412.
30. Wygrecka M, Markart P, Ruppert C, et al. Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb Haemost. 2004;92:529-540. (Pubitemid 39248009)
31. Maus U, Herold S, Muth H, et al. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol. 2001;280:L58-L68. (Pubitemid 32473238)
32. O'Mullane MJ, Baker MS. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation. Exp Cell Res. 1998;242: 153-164.
33. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alphaenolase as a candidate plasminogen receptor. Biochemistry. 1991;30:1682-1691.
34. Collen D, Tytgat G, Claeys H, Verstraete M, Wallén P. Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. J Clin Invest. 1972;51:1310-1318.
35. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 1998;91:2005-2009. (Pubitemid 28185501)
36. Busuttil SJ, Ploplis VA, Castellino FJ, Tang L, Eaton JW, Plow EF. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost. 2004;2:1798-1805. (Pubitemid 40192722)
37. Swaisgood CM, Schmitt D, Eaton D, Plow EF. In vivo regulation of plasminogen function by plasma carboxypeptidase B. J Clin Invest. 2002; 110:1275-1282.
38. Felez J, Miles LA, Plescia J, Plow EF. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines. J Cell Biol. 1990;111:1673-1683. (Pubitemid 20336503)
39. Das R, Burke T, Plow EF. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood. 2007;110:3763-3772. (Pubitemid 350159647)
40. Brownstein C, Deora AB, Jacovina AT, et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood. 2004;103:317-324. (Pubitemid 38029955)
41. 1. J Biol Chem. 2004;279:37528-37534.
42. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem. 2002;277:33564-33570. (Pubitemid 35056160)
43. Laumonnier Y, Syrovets T, Burysek L, Simmet T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood. 2006;107: 3342-3349.
44. Burysek L, Syrovets T, Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem. 2002;277:33509-33517. (Pubitemid 34987557)
45. Syrovets T, Tippler B, Rieks M, Simmet T. Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood. 1997;89:4574-4583. (Pubitemid 27260268)
46. Maus UA, Janzen S, Wall G, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol. 2006;35:227-235. (Pubitemid 44175323)
47. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997;17:439-444. (Pubitemid 27518393)
48. Legrand C, Polette M, Tournier JM, et al. uPA/ plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res. 2001;264:326-336. (Pubitemid 32980237)
49. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, et al. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem. 1993;268:11951-11958. (Pubitemid 23168155)
50. Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ. Plasminogen-dependent activation of latent transforming growth beta (TGF beta) by growing cultures of osteoblast-like cells. J Cell Physiol. 1993;157:528-534. (Pubitemid 23361181)